RecruitingNot ApplicableNCT06116253

Advanced Diffusion Imaging in Renal Cancer Patients

Advanced Diffusion Imaging in Renal Cancer Patients: Oncologic Control and Renal Functional Reserve


Sponsor

NYU Langone Health

Enrollment

90 participants

Start Date

Dec 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.


Eligibility

Min Age: 21 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study tests advanced MRI imaging techniques to better characterize kidney masses before surgery. The goal is to improve doctors' ability to tell whether a kidney tumor is cancerous and how aggressive it is, potentially reducing unnecessary surgeries. **You may be eligible if:** - You are between 21 and 85 years old - You have a kidney mass (growth) and are scheduled for laparoscopic partial kidney removal - Your kidney function is adequate (eGFR above 30) - You are willing and able to give consent **You may NOT be eligible if:** - You have metal or dental implants that are unsafe in a 3 Tesla MRI scanner - You are pregnant - You experience acute claustrophobia (fear of enclosed spaces) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMagnetic Resonance Imaging (MRI) Scan

Participants will undergo a 1-hour research MRI scan.

DRUGTc-99m Pentetate

Participants will receive radioisotope (99mTc-DTPA) injection (5 mCi) during 3-5 hour scanning session to estimate measured glomerular filtration rate (mGFR).


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06116253


Related Trials